Molecular targets for pharmacological cytoprotection

Biochemical Pharmacology

Volumn 61, Issue 7, 2001, Pages 769-777

  Balla, András ^a   Tóth, Balázs ^b   Timár, György ^c   Bak, Judit ^c   Krajcsi, Peter ^c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Apoptosis; Caspase; Cytoprotection; NF B; NOS; PARP

Indexed keywords

1,2 PROPANEDIAMINE N,N' DIACETAMIDE N,N' DIACETIC ACID; 2 (3 AMINOPROPYLAMINO)ETHANETHIOL; ACETYLCYSTEINE; AMIFOSTINE; ANTINEOPLASTIC AGENT; BIMOCLOMOL; CAMPTOTHECIN; CASPASE; CASPASE INHIBITOR; CEP 1347; CISPLATIN; CYCLOSPORIN A; CYTOSKELETON PROTEIN; DOXORUBICIN; FREE RADICAL; GLUTATHIONE DERIVATIVE; GLUTATHIONE DIESTER DERIVATIVE; GLUTATHIONE MONOESTER DERIVATIVE; HYDROXAMIC ACID DERIVATIVE; IRON CHELATE; LAZAROID DERIVATIVE; MANGANESE SALEN CHLORIDE; MESNA; NITRIC OXIDE SYNTHASE INHIBITOR; NUCLEASE; O (2 HYDROXY 3 PIPERIDINOPROPYL)NICOTINIC AMIDOXIME; PHOSPHOTRANSFERASE; RAZOXANE; SELEGILINE; STEROID; STREPTOMYCIN; TACROLIMUS; THIOL DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; BIOMECHANICS; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CANCER; CARDIOTOXICITY; CELL DEATH; CELL PROTECTION; CELL REGENERATION; CLINICAL FEATURE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME SUBSTRATE; HOMEOSTASIS; HUMAN; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; TISSUE INJURY; VASCULAR DISEASE;

EID: 0035313001     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00585-2     Document Type: Article

References (100)

1. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture
2. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
3. Apoptosis and the nervous system
4. The cellular response to p53: The decision between life and death
5. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide
6. Free radicals, 'reactive species' and toxicology
7. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
8. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
9. A model for p53-induced apoptosis
10. Mitochondrial control of apoptosis
11. Emerging roles of caspase-3 in apoptosis
12. Redox regulation of programmed cell death in lymphocytes
13. Metabolic activation and hepatotoxicity. Effects of cysteine, N-acetylcysteine, and methionine on glutathione biosynthesis and bromobenzene toxicity in isolated rat hepatocytes
14. Stimulation of hepatic glutathione formation by administration of l-2-oxothiazolidine-4-carboxylate, a 5-oxo-l-prolinase substrate
15. Effects of ifosfamide on immunocompetent effector cells
16. Transport of glutathione diethyl ester into human cells
17. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action
18. Thiol WR-1065 and disulphide WR-33278, two metabolites of the drug Ethyol (WR-2721), protect DNA against fast neutron-induced strand breakage
19. A risk-benefit assessment of amifostine in cytoprotection
20. The chemistry of free radicals and related 'reactive species'
21. Brain iron delocalization and lipid peroxidation following cardiac arrest
22. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury
23. Intramuscular desferrioxamine in patients with Alzheimer disease
24. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation
25. A new class of compounds for stroke and trauma: Effects of 21-aminosteroids on lipid peroxidation
26. Zinecard (dexrazoxone) product information
27. Pharmacodynamics of the hydrolysis-activation of the cardioprotective agent (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane
28. The hydrolysis product of ICRF-187 promotes iron-catalysed hydroxyl radical production via the Fenton reaction
29. Salen-manganese complexes are superoxide dismutase-mimics
30. Salen-manganese complexes: Combined superoxide dismutase/catalase mimics with broad pharmacological efficacy
31. A novel biologically active seleno-organic compound - I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen)
32. Multicenter randomized clinical trial of ebselen with aneurysmal subarachnoidal hemorrhage
33. The reaction of ebselen with peroxynitrite
34. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase
35. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in γ-radiation-induced apoptosis
36. Etoposide-induced activation of c-jun N-terminal kinase (JNK) correlates with drug-induced apoptosis in salivary gland acinar cells
37. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons
38. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-κB in cellular models of Parkinson's disease
39. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
40. Stress-activated protein kinases: Activation, regulation and function
41. Activation of the c-Jun N-terminal kinase/stress-activated kinase pathway by overexpression of caspase-8 and its homologs
42. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation
43. p53 is essential for developmental neuron death and regulated by TrkA and p75 neurotrophin receptors
44. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death
45. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway
46. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo
47. Chronic sparing of delayed alternation performance and choline acetyltransferase activity by CEP-1347/KT-7515 in rats with lesions of nucleus basalis magnocellularis
48. Cellular euthanasia mediated by a nuclear enzyme: A central role for nuclear ADP-ribosylation in cellular metabolism
49. Role of poly(ADP-ribose) formation in DNA repair
50. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease
51. Apoptosis in the absence of poly(ADP-ribose) polymerase
52. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
53. Inhibition of the activity of poly(ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle
54. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly(ADP-ribose) polymerase-1 deficient mice
55. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin
56. A20 inhibits cytokine-induced apoptosis and nuclear factor κB-dependent gene activation in islets
57. Generation of reactive oxygen intermediates, activation of NF-κB, and induction of apoptosis in human endothelial cells by glucose: Role of nitric oxide synthase?
58. Nitric oxide in excitable tissues: Physiological roles and disease
59. Nuclear factor-κB/Rel proteins
60. Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors
61. Inhibitors and activators of ADP-ribosylation reactions
62. Lessons learned from nitric oxide synthase knockout animals
63. Required and nonessential functions of nuclear factor-kappaB in bone cells
64. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-κB1) but expressing p50
65. BGP-15, a nicotinic amidoxime derivative protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase
66. Chemoprotective effect of BGP-15 in combination with anti-tumor drugs
67. Poly(ADP-ribose) polymerase, a potential target for drugs: Cellular regulatory role of the polymer and the polymerase protein mediated by catalytic and macromolecular colligative actions
68. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase
69. 2BP)
70. p53 mutations in human cancers
71. Mechanisms of p53-induced apoptosis
72. Pharmacological rescue of mutant p53 conformation and function
73. Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes
74. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
75. Deciphering the pathways of life and death
76. Caspase knockouts: Matters of life and death
77. Inhibition of human caspases by peptide-based and macromolecular inhibitors
78. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
79. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
80. Neuroprotection by a caspase inhibitor in acute bacterial meningitis
81. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation
82. Neuroprotective therapies
83. Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
84. Inhibition of anoxia-mediated injury in heart myocytes by cyclosporin A
85. Protection by cyclosporine A of cultured hepatocytes from the toxic consequences of the loss of mitochondrial energization by 1-methyl-4-phenylpyridinium
86. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin
87. Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents
88. TNF and cancer therapy-induced apoptosis. Potentiation by inhibition of NF-κB
89. NF-κB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type
90. Janus faces of nitric oxide
91. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
92. Bimoclomol: A nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects
93. The multiple cytoprotective pathways of Bimoclomol: The possible consequences of the drug-lipid interaction
94. Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols
95. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system
96. Histochemistry: Localized areas of high alkaline phosphatase activity in endothelium of arteries
97. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid
98. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene
99. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus
100. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids